Lilly inks $3.2B Morphic buyout to take on Takeda in IBD - Fierce Biotech
- Lilly inks $3.2B Morphic buyout to take on Takeda in IBD Fierce Biotech
- Eli Lilly to Buy Morphic Holding for $3.2 Billion The Wall Street Journal
- Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal Yahoo Finance
- Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company Investors | Eli Lilly and Company